AMBRE SOINS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AMBRE SOINS
Largest movements
- Receivables within one year +€33,354
new in 2025: €33,354
- Cash +€4,100
up €4,100 (+93.1%), from €4,404 to €8,504
mainly Net result for the year (+€31,557) and Deferred charges and accrued income (+€2,538)
- Deferred charges and accrued income -€2,538
down €2,538 (-21.1%), from €12,005 to €9,467
- Profit (loss) carried forward +€31,557
up €31,557 (+36.3%), from €87,003 to €118,561
- Tax, wage and social debts +€2,157
up €2,157 (+14.0%), from €15,421 to €17,578
- Trade debts +€1,620
up €1,620 (+103%), from €1,566 to €3,186
- Gross operating margin -€63,136
down €63,136 (-58.2%), from €108,497 to €45,362
- Taxes -€11,765
down €11,765 (-49.2%), from €23,921 to €12,157
- Financial charges +€2,842
up €2,842 (+648%), from €439 to €3,281
- Other operating charges +€2,130
up €2,130 (+424%), from €502 to €2,633
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €106,409 | €141,324 | +€34,916 | +32.8% |
| Current assets | 29/58 | €106,409 | €141,324 | +€34,916 | +32.8% |
| Amounts receivable after more than one year | 29 | €90,000 | €90,000 | = | 0.0% |
| Other amounts receivable | 291 | €90,000 | €90,000 | = | 0.0% |
| Amounts receivable within one year | 40/41 | - | €33,354 | +€33,354 | |
| Other amounts receivable | 41 | - | €33,354 | +€33,354 | |
| Cash at bank and in hand | 54/58 | €4,404 | €8,504 | +€4,100 | +93.1% |
| Deferred charges and accrued income | 490/1 | €12,005 | €9,467 | -€2,538 | -21.1% |
| Total equity and liabilities | 10/49 | €106,409 | €141,324 | +€34,916 | +32.8% |
| Equity | 10/15 | €89,003 | €120,561 | +€31,557 | +35.5% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Capital | 10 | €2,000 | - | -€2,000 | |
| Issued capital | 100 | €2,000 | - | -€2,000 | |
| Profit (loss) carried forward | 14 | €87,003 | €118,561 | +€31,557 | +36.3% |
| Amounts payable | 17/49 | €17,405 | €20,764 | +€3,358 | +19.3% |
| Amounts payable within one year | 42/48 | €17,405 | €20,764 | +€3,358 | +19.3% |
| Trade debts | 44 | €1,566 | €3,186 | +€1,620 | +103% |
| Suppliers | 440/4 | €1,566 | €3,186 | +€1,620 | +103% |
| Taxes, remuneration and social security | 45 | €15,421 | €17,578 | +€2,157 | +14.0% |
| Taxes | 450/3 | €15,421 | €17,578 | +€2,157 | +14.0% |
| Other amounts payable | 47/48 | €418 | €0 | -€418 | -100% |
| Other operating charges | 640/8 | €502 | €2,633 | +€2,130 | +424% |
| Gross operating margin | 9900 | €108,497 | €45,362 | -€63,136 | -58.2% |
| Operating profit (loss) | 9901 | €107,995 | €42,729 | -€65,266 | -60.4% |
| Financial income | 75/76B | €3,369 | €4,266 | +€897 | +26.6% |
| Recurring financial income | 75 | €3,369 | €4,266 | +€897 | +26.6% |
| Financial charges | 65/66B | €439 | €3,281 | +€2,842 | +648% |
| Recurring financial charges | 65 | €439 | €3,281 | +€2,842 | +648% |
| Profit (loss) for the period before taxes | 9903 | €110,925 | €43,714 | -€67,211 | -60.6% |
| Income taxes | 67/77 | €23,921 | €12,157 | -€11,765 | -49.2% |
| Profit (loss) for the period | 9904 | €87,003 | €31,557 | -€55,446 | -63.7% |
| Profit (loss) for the period to be appropriated | 9905 | €87,003 | €31,557 | -€55,446 | -63.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.